The DEA wants to grow more weed and mushrooms for research purposes

The DEA wants to double the amount of cannabis and psychedelics grown for research

That doesn’t seem like good news

The Drug Enforcement Administration (DEA) issued a note earlier this month announcing its intention to propose a much larger increase in cannabis cultivation for research by next year. The notice specifically mentions that they plan to boost production of psychedelics like psilocin, mescaline and LSD, reports Marijuana Moment.

The notice proposed the production of approximately 14,770 pounds of marijuana for 2023. In 2021, their proposal was to grow 2 million grams, and for 2022 it was 3.2 million grams. The recent request is nearly twice the growth of marijuana.

In addition, the DEA also wants to increase the production of psilocybin. Since there has been a psychedelic revolution in the United States in recent years, with localities and states decriminalizing psychedelics, more people than ever are curious about their healing properties. This year, the production quota for psilocybin was 8,000 grams, but the DEA wants to look at manufacturing psilocyn, another important compound found in magic mushrooms, from 4,000 to 8,000 grams. Among other psychedelics that the DEA would like to explore are LSD, mescaline and 5-MeO-DMT.

Is this really good news, or do they want to create biased, one-sided studies that only reveal the negative side effects of these therapeutic substances? Let’s take a tri

Because not so long ago, earlier this year, on January 12, 2022, the DEA already wanted to criminalize psychedelics. Docket #DEA-623, based on a 2012 Health and Human Services report, was proposed by the DEA. It recommends moving 5 psychedelic drugs (that are so obscure) to the Schedule 1 category. These drugs include, but are not limited to, Moxy, Alpha-O, and Iprocin, all of which are tryptamines that belong to the same class of drugs as LSD and magic mushrooms.

Why 2022? Why these obscure drugs? Why now when we are trying to decriminalize cannabis nationwide and make more psychedelics available to all who need it?

It is also ironic that the DEA CORRECTLY proposed such a rule when dozens of clinical studies poured in on the therapeutic benefits of psychedelics. Psychedelics have been shown to treat a variety of mental and physical ailments, particularly where pharmaceutical drugs have failed.

The filing was open to public comment until February 14, but it’s not surprising that many of the responses were critical of the DEA.

“Actions like this are completely misguided and actually contribute negatively to the so-called war on drugs,” said one commenter. “As these substances are banned, they will be replaced by increasingly obscure and complicated chemicals with even more questionable safety profiles. Please pause and consider the potential implications of such a decision,” they continued.

You are not wrong.

No wonder the DEA backed out of their plan to ban these psychedelics.

What Will President Biden Do About Marijuana Classification?

Recently, US President Joe Biden made an announcement through videotaping that there were new executive actions aimed at addressing current attitudes toward marijuana in the United States. Since, as of this writing, 37 states have already legalized cannabis for medical use and 19 states recreationally, it just doesn’t make sense that people should suffer for past federal offenses that only involve possession of the drug.

Biden said a new executive order would pardon all previous federal property crimes, severely impacting the lives of over 6,500 Americans. However, he also had a second announcement urging governors to also issue pardons for state cannabis possession offenses. He also called for a federal review of marijuana’s current classification because it’s still a Schedule 1 substance — in the same category as LSD and heroin.

“Like I said when I was running for president, no one should be in prison just for using or possessing marijuana,” he said in a statement. “It’s legal in many states, and criminal convictions for marijuana possession have created unnecessary barriers to employment, housing and educational opportunities,” he continued.

According to senior government officials, Biden will continue to impose restrictions to control underage marijuana sales and trafficking. “The President has made it clear that our marijuana laws are not working,” an administration official told reporters. “Members of Congress have been working on this issue, but that effort has stalled. And we’re almost at the end of the convention. So, the President has considered his options and is now taking executive action to address the country’s failed marijuana policy,” they said.

Necessary measures? Where are the changes?

In the face of all this, it’s fair to say that the DEA and the US government are simply lacking in action. They have much to say about the failure of the war on drugs, trafficking, underage sale, Schedule 1, decriminalization, abuse and much more.

But here we ask: Where are the actions that follow?

With 2023 fast approaching, marijuana is still a Schedule 1 substance. Meanwhile, the DEA is interested in making obscure Schedule 1 psychedelics. Sure, they want to study drugs more, but where is all this going? Are they really going to make an effort to make the lives of millions of Americans easier by increasing access to much-needed natural remedies, or is it all just a front?

America needs action, not words.

THE DEA WANTS MORE CANNABIS, READ MORE…

DEA PLANS TO GROW MORE WEED IN 2022, UMM SAY WHAT??